NCT03982602

Brief Summary

Traumatic Brain Injury is a major health concern in United States. There is a un-met need to develop new therapeutic options for faster neuron recovery without causing significant side effects. The role of ketones in neuronal recovery has been studied and has been found to be useful in decreasing size of contusion. The present study aims to study the safety and feasibility profile of ketogenic diet.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started Jul 2019

Longer than P75 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2019

Completed
23 days until next milestone

Study Start

First participant enrolled

July 4, 2019

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

May 3, 2024

Status Verified

May 1, 2024

Enrollment Period

4.8 years

First QC Date

June 3, 2019

Last Update Submit

May 2, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Effect of Ketogenic Diet on Intracranial Pressure

    Intracranial Pressure will be measured hourly and it will be trended daily.

    Baseline, till patient on KD (maximim 1 month)

  • Development of Ketosis in blood

    Serum beta-hydroxybutyrate will be done alternate day to assess the level of ketosis in blood.

    Baseline, till patient on KD ( maximum 1month)

  • Excretion of Ketones in Urine

    Urine Ketones will be measured alternate day to assess the level of ketosis

    Baseline, till patient on KD (maximum 1 month)

Secondary Outcomes (3)

  • Evaluate change in the neurological exam

    Baseline, before discharge from ICU

  • Evaluate subjects with gastro-intestinal adverse effects

    Baseline, till patient on KD (Maximum 1month)

  • Evaluate subjects for muscle wasting

    Baseline, till patient on Kd (Maximum 1month)

Study Arms (1)

Subjects on Ketogenic diet

EXPERIMENTAL

Treatment with KD will consist of 4:1 \[fat\]: \[protein + carbohydrate\] weight ratio. KD will be started as soon as the patient is ready for alimentation (while they are in neurocritical care unit). The rate of feeds will be calculated by trained dietician on service. Ketogenic diet will be continued during the entire length of ICU stay. Supplementation with vitamins, calcium and phosphorus will be done.

Other: Ketogenic diet

Interventions

Subjects will be provided with the Ketogenic diet in the form of tube feeds once the decision is made to start the patient on diet.

Also known as: Ketovie
Subjects on Ketogenic diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Severe Traumatic Brain Injury
  • GCS\<= 8 with severe head injury
  • Age more than 18years

You may not qualify if:

  • Diabetic Ketoacidosis
  • Unstable metabolic condition (persistent hyponatremia, hypernatremia, hypoglycemia, hypocalcemia, acidosis)
  • Cardiorespiratory or hemodynamic instability
  • Coagulopathy
  • Pancreatitis
  • Liver Failure
  • Severe hyperlipidemia
  • Inability to tolerate enteral feeds including ileus
  • Known Fatty acid oxidation disorder or pyruvate carboxylase deficiency
  • Any terminally ill patient with poor brain stem reflexes and mortality within 24h of admission.
  • Pregnant Females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri Hospital

Columbia, Missouri, 65212, United States

Location

Related Publications (1)

  • Arora N, Litofsky NS, Golzy M, Aneja R, Staudenmyer D, Qualls K, Patil S. Phase I single center trial of ketogenic diet for adults with traumatic brain injury. Clin Nutr ESPEN. 2022 Feb;47:339-345. doi: 10.1016/j.clnesp.2021.11.015. Epub 2021 Nov 16.

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Diet, Ketogenic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Diet, Carbohydrate-RestrictedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 3, 2019

First Posted

June 11, 2019

Study Start

July 4, 2019

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

May 3, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations